A clinical-grade constitutive packaging cell line for the production of self-inactivating lentiviral vectors

被引：0
|
作者：
Knight, Sean [1 ,2 ]
Sanber, Khaled [1 ,2 ]
Stephen, Sam [1 ,2 ]
Ferraresso, Marta [1 ,2 ]
Baley, Ranbir [1 ,2 ]
Escors, David [1 ,2 ]
Santilli, Giorgia [3 ]
Thrasher, Adrian [3 ]
Collins, Mary [1 ,2 ]
Takeuchi, Yasu [1 ,2 ]
机构：
[1] UCL, UCL Canc Inst, MRC UCL Ctr Med Mol Virol, London, England
[2] UCL, UCL Canc Inst, Wohl Virion Ctr, Div Infect & Immun, London, England
[3] UCL, Inst Child Hlth, Mol Immunol Unit, Ctr Immunodeficiency, London, England
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P142
引用
收藏
页码：A101 / A102
页数：2
相关论文
共 50 条
  • [1] A clinical-grade constitutive packaging cell line for the production of self-inactivating lentiviral vectors
    Knight, Sean
    Sanber, Khaled
    Stephen, Sam
    Bailey, Ranbir
    Escors, David
    Santilli, Giorgia
    Thrasher, Adrian
    Collins, Mary
    Takeuchi, Yasu
    HUMAN GENE THERAPY, 2013, 24 (05) : A23 - A23
  • [2] Use of the piggyBac Transposon to Create Stable Packaging Cell Lines for the Production of Clinical-Grade Self-Inactivating γ-Retroviral Vectors
    Feldman, Steven A.
    Xu, Hui
    Black, Mary A.
    Park, Tristen S.
    Robbins, Paul F.
    Kochenderfer, James N.
    Morgan, Richard A.
    Rosenberg, Steven A.
    HUMAN GENE THERAPY METHODS, 2014, 25 (04) : 253 - 260
  • [3] A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating γ-retroviral vectors using targeted integration
    R Loew
    Y Meyer
    K Kuehlcke
    L Gama-Norton
    D Wirth
    H Hauser
    S Stein
    M Grez
    S Thornhill
    A Thrasher
    C Baum
    A Schambach
    Gene Therapy, 2010, 17 : 272 - 280
  • [4] A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating γ-retroviral vectors using targeted integration
    Loew, R.
    Meyer, Y.
    Kuehlcke, K.
    Gama-Norton, L.
    Wirth, D.
    Hauser, H.
    Stein, S.
    Grez, M.
    Thornhill, S.
    Thrasher, A.
    Baum, C.
    Schambach, A.
    GENE THERAPY, 2010, 17 (02) : 272 - 280
  • [5] Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection
    van der Loo, J. C. M.
    Swaney, W. P.
    Grassman, E.
    Terwilliger, A.
    Higashimoto, T.
    Schambach, A.
    Baum, C.
    Thrasher, A. J.
    Williams, D. A.
    Nordling, D. L.
    Reeves, L.
    Malik, P.
    GENE THERAPY, 2012, 19 (03) : 246 - 254
  • [6] Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection
    J C M van der Loo
    W P Swaney
    E Grassman
    A Terwilliger
    T Higashimoto
    A Schambach
    C Baum
    A J Thrasher
    D A Williams
    D L Nordling
    L Reeves
    P Malik
    Gene Therapy, 2012, 19 : 246 - 254
  • [7] Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors
    Xu, KL
    Ma, H
    McCown, TJ
    Verma, IM
    Kafri, T
    MOLECULAR THERAPY, 2001, 3 (01) : 97 - 104
  • [8] A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors
    Cockrell, Adam S.
    Ma, Hong
    Fu, Kailing
    McCown, Thomas J.
    Kafri, Tal
    MOLECULAR THERAPY, 2006, 14 (02) : 276 - 284
  • [9] RD3-MolPack packaging cells for stable production of Tat-independent self-inactivating lentiviral vectors
    Stornaiuolo, A.
    Bossi, S.
    Corna, S.
    Zucchelli, E.
    Bordignon, C.
    Rizzardi, G. P.
    Bovolenta, C.
    HUMAN GENE THERAPY, 2013, 24 (12) : A95 - A95
  • [10] Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo
    Cesana, Daniela
    Ranzani, Marco
    Volpin, Monica
    Bartholomae, Cynthia
    Duros, Caroline
    Artus, Alexandre
    Merella, Stefania
    Benedicenti, Fabrizio
    Sergi, Lucia Sergi
    Sanvito, Francesca
    Brombin, Chiara
    Nonis, Alessandro
    Di Serio, Clelia
    Doglioni, Claudio
    von Kalle, Christof
    Schmidt, Manfred
    Cohen-Haguenauer, Odile
    Naldini, Luigi
    Montini, Eugenio
    MOLECULAR THERAPY, 2014, 22 (04) : 774 - 785
12345